Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro.
about
Evaluation of transduction efficiency in macrophage colony-stimulating factor differentiated human macrophages using HIV-1 based lentiviral vectorsDendritic cells for specific cancer immunotherapy.An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice.Adenovirus as an emerging pathogen in immunocompromised patients.Immunotherapy for gynaecological malignancies.Lentiviral vectors for immunization: an inflammatory field.New approaches to the development of adenoviral dendritic cell vaccines in melanoma.Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor-specific CD8+ T cells: implications for an efficient vaccination strategy.Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus.Intratumoral injection of dendritic cells after treatment of anticancer drugs induces tumor-specific antitumor effect in vivo.Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production.Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma.Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity.
P2860
Q33807916-3BC46E02-A045-494D-A43E-ADC5D5A6D8D9Q34280913-8754E02B-5A8F-456F-9546-C227A0AB8940Q34810377-6FCACEFD-A2D6-430A-ABE5-AD8E70D6A343Q36003090-6DA9A325-D907-4424-BEAB-AF26092D9C51Q36239661-BC9E3FE4-30E6-43DB-B035-69EF37AD7BAFQ37706590-26394695-92A4-4F71-9800-E3649B6EBE80Q37820489-CC6F415C-583B-4870-BFDE-D1E65E0231E1Q39547016-45605921-A3E5-432A-8E0B-36B8D1D5E0ECQ39683371-34BF2AC2-6BAC-404B-AFF8-66B22082220FQ40672509-814360F3-650C-4CD4-8BC4-BEE4291AE50AQ41847338-8FC4FDAF-0BD6-4FC9-B0E8-E531CB1838F8Q43069927-271725E1-C03E-4DC7-88B9-0AAEE9D8E31AQ44124433-A794455F-7D96-461D-8034-17D7CCE7771AQ44626008-2CCC95B0-F689-44CF-82B1-DB7FCCFF4C7BQ45736315-05C1D703-5C7F-403E-9DA2-EBC8E03BBDA0Q45865610-E6CE7D90-70CC-4FBE-AAD2-505C82BF9A05
P2860
Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Human PBMC-derived dendritic c ...... ctor-encoded antigen in vitro.
@en
Human PBMC-derived dendritic c ...... ctor-encoded antigen in vitro.
@nl
type
label
Human PBMC-derived dendritic c ...... ctor-encoded antigen in vitro.
@en
Human PBMC-derived dendritic c ...... ctor-encoded antigen in vitro.
@nl
prefLabel
Human PBMC-derived dendritic c ...... ctor-encoded antigen in vitro.
@en
Human PBMC-derived dendritic c ...... ctor-encoded antigen in vitro.
@nl
P2093
P2860
P356
P1433
P1476
Human PBMC-derived dendritic c ...... ector-encoded antigen in vitro
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3300899
P577
1999-05-01T00:00:00Z
P5875
P6179
1025706307